Literature DB >> 25548484

Claudin 1 mediates tumor necrosis factor alpha-induced cell migration in human gastric cancer cells.

Atsushi Shiozaki1, Hiroki Shimizu1, Daisuke Ichikawa1, Hirotaka Konishi1, Shuhei Komatsu1, Takeshi Kubota1, Hitoshi Fujiwara1, Kazuma Okamoto1, Daisuke Iitaka1, Shingo Nakashima1, Yoshito Nako1, Mingyao Liu1, Eigo Otsuji1.   

Abstract

AIM: To investigate the role of claudin 1 in the regulation of genes involved in cell migration and tumor necrosis factor alpha (TNF-α)-induced gene expression in human gastric adenocarcinoma cells.
METHODS: Knockdown experiments were conducted with claudin 1 small interfering RNA (siRNA), and the effects on the cell cycle, apoptosis, migration and invasion were analyzed in human gastric adenocarcinoma MKN28 cells. The gene expression profiles of cells were analyzed by microarray and bioinformatics.
RESULTS: The knockdown of claudin 1 significantly inhibited cell proliferation, migration and invasion, and increased apoptosis. Microarray analysis identified 245 genes whose expression levels were altered by the knockdown of claudin 1. Pathway analysis showed that the top-ranked molecular and cellular function was the cellular movement related pathway, which involved MMP7, TNF-SF10, TGFBR1, and CCL2. Furthermore, TNF- and nuclear frctor-κB were the top-ranked upstream regulators related to claudin 1. TNF-α treatment increased claudin 1 expression and cell migration in MKN28 cells. Microarray analysis indicated that the depletion of claudin 1 inhibited 80% of the TNF-α-induced mRNA expression changes. Further, TNF-α did not enhance cell migration in the claudin 1 siRNA transfected cells.
CONCLUSION: These results suggest that claudin 1 is an important messenger that regulates TNF-α-induced gene expression and migration in gastric cancer cells. A deeper understanding of these cellular processes may be helpful in establishing new therapeutic strategies for gastric cancer.

Entities:  

Keywords:  Cell migration; Claudin 1; Gene expression change; Microarray; Tumor necrosis factor alpha

Mesh:

Substances:

Year:  2014        PMID: 25548484      PMCID: PMC4273136          DOI: 10.3748/wjg.v20.i47.17863

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail.

Authors:  Junichi Ikenouchi; Miho Matsuda; Mikio Furuse; Shoichiro Tsukita
Journal:  J Cell Sci       Date:  2003-03-26       Impact factor: 5.285

Review 2.  Barriers built on claudins.

Authors:  Kursad Turksen; Tammy-Claire Troy
Journal:  J Cell Sci       Date:  2004-05-15       Impact factor: 5.285

3.  The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation.

Authors:  Tadashi Ohkubo; Masayuki Ozawa
Journal:  J Cell Sci       Date:  2004-03-09       Impact factor: 5.285

4.  Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.

Authors:  Murray B Resnick; Mariuxi Gavilanez; Eric Newton; Tamako Konkin; Baishali Bhattacharya; Deborah E Britt; Edmond Sabo; Steven F Moss
Journal:  Hum Pathol       Date:  2005-08       Impact factor: 3.466

5.  Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Authors:  Punita Dhawan; Amar B Singh; Natasha G Deane; Yiran No; Sheng-Ru Shiou; Carl Schmidt; John Neff; M Kay Washington; R Daniel Beauchamp
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

Review 6.  Role of claudins in tumorigenesis.

Authors:  Karen Swisshelm; Robert Macek; Manfred Kubbies
Journal:  Adv Drug Deliv Rev       Date:  2005-04-25       Impact factor: 15.470

7.  Tumor necrosis factor alpha disrupts tight junction assembly.

Authors:  Lisa S Poritz; Kristian I Garver; Anna F Tilberg; Walter A Koltun
Journal:  J Surg Res       Date:  2004-01       Impact factor: 2.192

8.  Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study.

Authors:  Murray B Resnick; Tamako Konkin; Justin Routhier; Edmond Sabo; Victor E Pricolo
Journal:  Mod Pathol       Date:  2005-04       Impact factor: 7.842

9.  Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells.

Authors:  Chang-Hwan Yoon; Min-Jung Kim; Myung-Jin Park; In-Chul Park; Sang-Gu Hwang; Sungkwan An; Yung-Hyun Choi; Gyesoon Yoon; Su-Jae Lee
Journal:  J Biol Chem       Date:  2009-11-06       Impact factor: 5.157

10.  Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids.

Authors:  Thorsten Hoevel; Robert Macek; Karen Swisshelm; Manfred Kubbies
Journal:  Int J Cancer       Date:  2004-01-20       Impact factor: 7.396

View more
  14 in total

1.  CLDN-1 promoted the epithelial to migration and mesenchymal transition (EMT) in human bronchial epithelial cells via Notch pathway.

Authors:  Jing Lv; Baohua Sun; Zhitao Mai; Mingming Jiang; Junfeng Du
Journal:  Mol Cell Biochem       Date:  2017-03-18       Impact factor: 3.396

2.  Claudin-1 promotes TNF-α-induced epithelial-mesenchymal transition and migration in colorectal adenocarcinoma cells.

Authors:  Ajaz A Bhat; Rizwan Ahmad; SrijayaPrakash B Uppada; Amar B Singh; Punita Dhawan
Journal:  Exp Cell Res       Date:  2016-10-11       Impact factor: 3.905

3.  The Role of cIAP1 and XIAP in Apoptosis Induced by Tumor Necrosis Factor Alpha in Esophageal Squamous Cell Carcinoma Cells.

Authors:  Shoichiro Hikami; Atsushi Shiozaki; Maki Kitagawa-Juge; Daisuke Ichikawa; Toshiyuki Kosuga; Hirotaka Konishi; Shuhei Komatsu; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Dig Dis Sci       Date:  2017-01-03       Impact factor: 3.199

Review 4.  Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier.

Authors:  Tyler J Caron; Kathleen E Scott; James G Fox; Susan J Hagen
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

5.  Cycling hypoxia affects cell invasion and proliferation through direct regulation of claudin1 / claudin7 expression, and indirect regulation of P18 through claudin7.

Authors:  Hong Liu; Feifei Jiang; Xinshan Jia; Jing Lan; Hao Guo; Erran Li; Aihui Yan; Yan Wang
Journal:  Oncotarget       Date:  2017-02-07

6.  Lemon Peel Polyphenol Extract Reduces Interleukin-6-Induced Cell Migration, Invasiveness, and Matrix Metalloproteinase-9/2 Expression in Human Gastric Adenocarcinoma MKN-28 and AGS Cell Lines.

Authors:  Valentina Pagliara; Rosarita Nasso; Paola Di Donato; Ilaria Finore; Annarita Poli; Mariorosario Masullo; Rosaria Arcone
Journal:  Biomolecules       Date:  2019-12-05

7.  E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.

Authors:  Perla Yaceli Uc; Jael Miranda; Arturo Raya-Sandino; Lourdes Alarcón; María Luisa Roldán; Rodolfo Ocadiz-Delgado; Enoc Mariano Cortés-Malagón; Bibiana Chávez-Munguía; Georgina Ramírez; René Asomoza; Liora Shoshani; Patricio Gariglio; Lorenza González-Mariscal
Journal:  Int J Oncol       Date:  2020-07-29       Impact factor: 5.650

8.  Green tea polyphenols affect invasiveness of human gastric MKN-28 cells by inhibition of LPS or TNF-α induced Matrix Metalloproteinase-9/2.

Authors:  Rosaria Arcone; Margherita Palma; Valentina Pagliara; Giulia Graziani; Mariorosario Masullo; Gerardo Nardone
Journal:  Biochim Open       Date:  2016-11-05

9.  Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression.

Authors:  Taishi Akimoto; Akira Takasawa; Kumi Takasawa; Tomoyuki Aoyama; Masaki Murata; Makoto Osanai; Tsuyoshi Saito; Norimasa Sawada
Journal:  Neoplasia       Date:  2018-09-15       Impact factor: 5.715

10.  Gastric Cancer Heterogeneity and Clinical Outcomes.

Authors:  Rachel E Sexton; Mohammed Najeeb Al Hallak; Md Hafiz Uddin; Maria Diab; Asfar S Azmi
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.